Oberland Capital Management is pumping some new life into Biohaven, striking a unique investment deal worth up to $600 ...

Shares of Biohaven (NYSE: BHVN) are surging on Monday. The move comes as the S&P 500 traded mixed and the Nasdaq Composite ...

Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), a global clinical-stage biopharmaceutical company focused on the ...

Biohaven Ltd. (BHVN) shares rise premarket as it secures up to $600 million investment from Oberland Capital. Cash reserves ...

Biohaven will receive up to $600 million to support ongoing clinical trials and the full development of its portfolio.

Steminent Biotherapeutics specializes in developing innovative stem cell-based therapeutics that offer new hope for patients ...

Currently under review in the U.S. for a rare genetic disorder, the drug is seen by some investors as critical to Biohaven’s ...

Stemchymal® is an allogeneic adipose-derived mesenchymal stem cell (MSC) therapy developed for spinocerebellar ataxia (SCA), a rare neurodegenerative disease that is currently incurable.

Bill Nye "The Science Guy", renowned science educator and television personality, was a guest speaker at the National Ataxia Foundation’s Annual Ataxia Conference in Las Vegas on Saturday.

Spinocerebellar ataxia (SCA) is a neurodegenerative disorder affecting the cerebellum, a part of the brain responsible for coordinating movement. Symptoms include difficulties with balance ...

Considering taking supplements to treat spinocerebellar ataxia sca? Below is a list of common natural remedies used to treat or reduce the symptoms of spinocerebellar ataxia sca. Follow the links ...